You might also read
Articles linked to this work by shared authors, journal, and citation graph.
D Andrew James1, Lisa Szymkowicz1, Lois Yin1
1Sanofi, Toronto, ON, Canada.
Developing new recombinant protein vaccines against SARS-CoV-2 variants required rapid biochemical testing. A novel suite of assays, including reversed-phase high-performance liquid-chromatography and LC/MS/MS, supported accelerated decision-making for clinical trials.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: